Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Cell Culture market research products provide analysis of the latest trends, developments and market data for this industry. Research information will help you make informed business decisions.

older | 1 | (Page 2) | 3 | 4 | .... | 17 | newer

    0 0

    The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%. The emerging markets for cell culture products totaled $128.7 million in 2009 and reached $134.8 million in 2010. This market is expected to increase from $141.5 million in 2011 to $178.3 million by 2016, at a CAGR of 4.7%. Cell culture media sales in the emerging markets amounted to $52.2 million in 2009 and reached $54.9 million in 2010. Increasing at a CAGR of 5.2% the cell culture media market is expected to grow from $57.9 million in 2011 to $74.5 million by 2016.

    0 0

    The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%. The European market for cell culture products reached $718.8 million in 2010 and $775.8 million in 2011. It is expected to reach $1.1 billion by 2016, a CAGR of 8.0%. The European market for reagents products reached $314.7 million in 2010 and $347.9 million in 2011. It is expected to reach $594.7 million by 2016, a CAGR of 11.3%.

    0 0

    The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%. The reagents market reached $1 billion in 2010 and nearly $1.2 billion in 2011. It is expected to grow to $2 billion by 2016, a CAGR of 11.3%. The media segment reached $820.7 million in 2010 and $897.4 million in 2011. It is expected to grow to $1.4 billion by 2016, a CAGR of 9.4%.

    0 0

    The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%. The reagents market reached $1 billion in 2010 and nearly $1.2 billion in 2011. It is expected to grow to $2 billion by 2016, a CAGR of 11.3%. The media segment reached $820.7 million in 2010 and $897.4 million in 2011. It is expected to grow to $1.4 billion by 2016, a CAGR of 9.4%.

    0 0

    Biotechnology (life science and analytical) reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education. The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011. The global life science and analytical reagents market was valued at $40,308.8 million in 2011 and is expected to reach $59,319.2 million by 2016; growing at a CAGR of 8% from 2011 to 2016. The life sciences and analytical reagents market is driven by the increasing use of reagents in therapeutics, basic research and commercial applications. The demand for biotechnology reagents is mainly dependent upon the growth of the biotechnology instrumentation market. The biotechnology instrumentation market continues to witness significant growth due to an increase in the number of biotechnology firms around the globe and increase in research and

    0 0

    Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education. The biotechnology reagent market is vast; it consists of several technologies such as PCR, cell culture, IVD, expression and transfection, chromatography, spectrometry, electrophoresis, and flow cytometry. This report studies the biotechnology reagents market, by technology, end-users, and applications. The biotechnology reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011. The global biotechnology reagents market was valued at $40.3 billion in 2011 and is expected to reach $59.3 billion by 2016; growing at a CAGR of 8% from 2011 to 2016. The biotechnology reagents market is driven by the increasing use of reagents in therapeutics, basic research and commercial applications. The demand for biotechnology reagents is mainly dependent upon the growth of the biotechnology instrumentation market. The biotechnology instrumentation market continues to witness significant growth due to an increase in the number of biotechnology firms around the globe and

    0 0

    Over 200 pages of analysis based on a 37-question survey taken by 1,069 scientists. Train your sales team with this invaluable primary market research. In Life Science Sales Reps: A Guide to Best Practices in 2012, we explore the role of life science supplier sales reps and identify ways that sales teams can have a positive impact on scientists’ relationships with supplier companies. We surveyed over 1,000 scientists around the world to find out how much (or little) they rely on their sales reps when purchasing specific instruments and consumables. Are scientists depending on their sales reps for product information more or less than they did five years ago? Are they using mobile devices to browse catalogs? How can a sales rep be most useful when a lab is considering buying (or switching to) a new product? What purchasing channels are laboratories using, and which ones do they prefer? The answers to these questions and more are detailed in this study so that suppliers can adjust their practices to align with the way labs prefer to do business. Going beyond strategy, this report also serves as a tactical guide for individual sales reps. Extensive product lines and

    0 0

    Overview The growth and propagation of mammalian cells in culture is a routine but critical precursor to the investigation of such fundamental cellular processes as gene expression and protein function and to the development of therapeutics. Cell culture products are widely used not only by scientists working with traditional cell lines but also by researchers engaged in experiments with such emerging model systems as stem cells and engineered cell lines. This Cell Culture Dashboard for the Chinese market was developed based upon the aggregated responses to a 21-question survey and completed by 398 scientists actively engaged in mammalian cell culture predominantly located in China. This Dashboard reveals key market indicators for the research market for cell culture products as a whole as well as for the following product segments: Basal media Fetal bovine serum Animal sera Balanced salt solutions Serum free media Dry powdered media Growth and attachment factors Stem cell culture reagents Consistent with the previous series of Cell Culture Dashboards™ for North America and Europe, Percepta has launched the first in the series of Cell Culture Dashboards™ for the Chinese market.

    0 0

    The growth and propagation of mammalian cells in culture is a routine but critical precursor to the investigation of such fundamental cellular processes as gene expression and protein function and to the development of therapeutics. Cell culture products are widely used not only by scientists working with traditional cell lines but also by researchers engaged in experiments with such emerging model systems as stem cells and engineered cell lines. This Cell Culture Dashboard was developed based upon the aggregated responses to a 21-question survey completed by 487 scientists actively engaged in mammalian cell culture predominantly located in North America and Europe. This Dashboard reveals key market indicators for the research market for cell culture products as a whole as well as for the following product segments: Basal media Fetal bovine serum Animal sera Balanced salt solutions Serum free media Dry powdered media Growth and attachment factors Stem cell culture reagents Percepta’s 2012 Cell Culture Dashboard™, the fourth in a series of reports, examines the characteristics and dynamics of the market for cell culture products. This 2012 Dashboard provides a snapshot of the current market landscape that has

    0 0

    The Sexual Health Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the sexual health partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter sexual health partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sexual health technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

    0 0

    Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities Summary GBI Research, the leading business intelligence provider, has released its latest research “Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities”, which provides in-depth analysis on the processes, drivers and barriers of the cell culture market. The report analyzes the role of biopharmaceutical products that basically provide enhancement to media, sera, reagents and cell culture market. Major manufacturing technologies involved in the cell culture technology have been detailed in the report. Furthermore, the report provides competitive benchmarking for the leading players that shape the global media, sera, reagent and overall cell culture market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Cell culture technology is used to carry out processes external to the natural environment by maintaining controlled environments which enable the growth of various cell cultures for use in medicine and research. The processes is related to methods involved in the development of tissue or organ cultures. Multicellular eukaryotic cells from animals are usually preferred

    0 0
  • 09/30/12--22:00: Cell/Tissue Culture Supplies
  • This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 92 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., EMD Millipore, Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against

    0 0

    This report provides an overview of the life sciences research tools market from 2005 to 2015. Life sciences research tools companies offer instruments and reagents to laboratory scientists. Top vendors include ThermoFisher, Life Technologies (Invitrogen / Applied Biosystems), Sigma-Aldrich and Millipore. We divided this market in 5 broad segments: 1) pure genomics technologies (PCR, qPCR, digital PCR, CE sequencing, next generation sequencing (NGS) / third generation sequencing (3GS), microarrays, molecular biology tools), 2) pure proteomics technologies (protein isolation and analysis, ELISA, protein production, western blots and protein microarrays), 3) cell biology technologies (basic cell biology reagents, discovery services, media and sera, flow cytometry, transfection and electroporation, microscopy and automation, whole cell imaging, cell culture equipment, cells and tissues, high content imaging), 4) other analytical technologies (liquid chromatography, mass spectroscopy, in vivo study, sample preparation, multiplex technologies, magnetic beads) and 5) lab supplies and disposables. For each of these 29 subsegments, we present an analysis detailing sales of instruments and reagents from 2005 to 2015. In addition, we detail market drivers and moderators, market trends, a high level end-customer breakdown (Academic, BioPharma and Applied markets customers) and key competitors. Many of these technologies are increasingly used for

    0 0

    This report was created for strategic planners, international executives and import/export managers who are concerned with the market for prepared culture media for the development of micro-organisms. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for prepared culture media for the development of micro-organisms for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models. On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying prepared culture media for the development of micro-organisms? What is the dollar value of these imports? How much do the imports of prepared culture media for the development of micro-organisms vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of prepared culture media for the development of

    0 0

    Cell Culture: The Market for Media, Sera and Reagents - The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques have been used in biological sciences for more than 50 years; however, cell culture techniques have been applied to production systems for only about 26 years. The cell culture industry, which began in the late 1980s from the utilization of recombinant DNA technology and cell hybridization, is today a major underpinning of the biopharmaceutical market. The choice of cells to use in biopharmaceutical production depends on a number of factors, some technical and some economic. Bacteria and yeast, for instance, are relatively simple to grow. Each cell of a bacterium or yeast is an independent organism capable of its own metabolism. Yeasts and bacteria have fairly simple nutritional needs and grow well suspended in a liquid medium, as well as in large fermentors. This report is focused on cell culture used in the research and production of biopharmaceuticals. In the pharmaceutical industry, cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex

    0 0

    Following on from our hugely successful Cell-Based Assays conference in 2011 SMi will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet. Cell-Based Assays 2012 will show recent developments in ion channels, stem-cell platforms, label free assays and 3D cell culture. Recalls with drugs due to toxicity can cause R&D costs to spiral and can lead to huge wastes in research time. Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years. Recent increases in therapeutic use of stem cells has allowed increases in toxicity accuracy, also preventing the use of animal testing and cancerous cells Our 3-day event, formed of two half day post-conference workshops and a two-day conference will provide useful insights into the latest developments within Cell Based Assays. With an international array of speakers, enhance product launches or your own new developments with key decision makers from big pharma, biotech and academia.

    0 0

    This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for prepared culture media for the development of micro-organisms. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for prepared culture media for the development of micro-organisms for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models. In what follows, this report begins by summarizing the world exporter’s market for prepared culture media for the development of micro-organisms. The total level of exports on a worldwide basis is based on a model that aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on supply-side dynamics, market shares by

    0 0

    Basal media, fetal bovine media, and balanced salt solutions are prevalent cell culture media. However, serum free media and growth, as well as attachment factors, are expected to see increased use in 2013 because current non-users are planning to include them in their workflow. Overall, Asia-Pacific is still a growing market in terms of the number of cell culture users, but high pricing and high usage rates make it a very attractive one. With respect to selection drivers, product consistency and having a past relationship with a supplier are the two key features that drive cell culture selection.

    0 0

    Taking an international expert speaking faculty join us at SMi's Cell Culture conference due to take place on the 3 & 4 July 2013 in central London. Cell culture is set to see huge increases in growth including the recent advances in techniques such as 3D cell culture. The cell culture market is set to be worth £4.5 billion by 2020 driven by advances in pharma and biotech. Over the two day conference delegates will be exposed to leading decision makers in a range Cell Culture related fields from Europe and the States, listen to our keynote speakers on day one speak about the latest data coming back from culture techniques being used on the International Space Station. Day one will focus on the recent advances in 3D cell culture. Case studies will demonstrate how this method is providing highly physiologically accurate preclinical data and current approaches for culture in relevant diseases. Day two's speaking faculty will focus on cell culture process development and cell line development including the use of high throughput technologies. Our 3-day event, formed of two half day post-conference workshops and a two-day conference will

    0 0

    Over the past decade, the transient gene expression (TGE) technology platform has been actively pursued to produce a wide range of therapeutic proteins, monoclonal antibodies, and vaccines for mainly preclinical assessment, due to its short development times and low overall cost. This book updates the latest advances in the field, with focusing on systematic description of the technology from cell lines, cell culture conditions, vector construction, expression strategy, current protocols, optimisation of the procedure, and potential for clinical application. As a conclusion, the author foresees that therapeutic biopharmaceutics will be manufactured for clinical development using TGE technology in the near future because of its fast development time, good protein expression, acceptable quality of product and due to the progress which has been made in analytical methodology and process quality control. The objectives of this book are to summarise current TGE protocols, to describe optimisation of the technology through the latest advances, and to explore clinical applications of the technology. It gives the reader a good insight into the latest development and future application of the technology platform, including: The current protocols from small to large scale for different cells. Optimisation methods in construction designing,

older | 1 | (Page 2) | 3 | 4 | .... | 17 | newer